Tenecteplase provides comparable safety and effectiveness outcomes for acute ischemic stroke as alteplase, new research ...

Recombinant human prourokinase is noninferior to alteplase in acute ischemic stroke, with symptomatic intracranial hemorrhage and major bleeding decreased.

The FDA recently approved the first treatment in nearly 30 years for acute stroke, and the agency also approved a novel drug ...

The following is a summary of “Effect of sarcopenia on prognosis in patients with mild acute ischemic stroke: a prospective ...

The usage of tenecteplase in patients with acute ischemic stroke was associated with similar effectiveness and safety ...

The Food and Drug Administration (FDA) has approved TNKase ® (tenecteplase) for the treatment of acute ischemic stroke ... patients who achieved a modified Rankin Scale score of 0-1 at 90 ...

The risk of a full-blown stroke will remain high for at least a decade after a person has a slight brush with stroke, in the ...

Gastrointestinal complications are common in patients after ischemic stroke. Gastric motility is regulated by gastric pace-making activity (also called gastric myoelectrical activity (GMA)) and ...